Formulation and in-vitro evaluation of floating capsules of Loratadine
Abstract
The
present work focuses on the development of hydrodynamically balanced delivery
system of loratadine as a single unit floating capsules. Sustained release
floating capsules for loratadine were fabricated using drug:polymer ratio of
1:4. The hydrocolloids were used in different proportions using 32full factorial design and formulations were prepared.
These formulations were optimized on the basis of buoyancy, matrix integrity,
duration of floating and in vitrodrug release. All the nine formulations showed
good buoyancy and matrix integrity. The duration of floating was more than 12 h
for all formulations. In vitrodrug release study of these formulations indicated
controlled release of loratadine and abot 90 percent drug was released at the
end of 12 h.
Comments
Post a Comment